A combination treatment of IFN-α2b and IFN-γ accelerates viral clearance and control inflammatory response in COVID-19: Preliminary results of a randomized controlled trial
Open Access
- 15 June 2021
- journal article
- Published by Peertechz Publications Private Limited in Annals of Antivirals and Antiretrovirals
- Vol. 5 (1), 001-014
- https://doi.org/10.17352/aaa.000010
Abstract
Herpes simplex virus 1 is consistently the most common cause of sporadic encephalitis worldwide which leaves neurological deficits in more than 60% of survived patients.Keywords
This publication has 50 references indexed in Scilit:
- Systematic identification of type I and type II interferon-induced antiviral factorsProceedings of the National Academy of Sciences of the United States of America, 2012
- Regulation of neutrophils by interferon-γ limits lung inflammation during tuberculosis infectionThe Journal of Experimental Medicine, 2011
- Dynamic Innate Immune Responses of Human Bronchial Epithelial Cells to Severe Acute Respiratory Syndrome-Associated Coronavirus InfectionPLOS ONE, 2010
- Iron Chelators and Hypoxia Mimetics Inhibit IFNγ-Mediated Jak-STAT SignalingJournal of Investigative Dermatology, 2009
- IL-12 RB1 Genetic Variants Contribute to Human Susceptibility to Severe Acute Respiratory Syndrome Infection among ChinesePLOS ONE, 2008
- Interferon-γ and interleukin-4 downregulate expression of the SARS coronavirus receptor ACE2 in Vero E6 cellsVirology, 2006
- Interferon-beta and interferon-gamma synergistically inhibit the replication of severe acute respiratory syndrome-associated coronavirus (SARS-CoV)Virology, 2004
- Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findingsThorax, 2004
- The Critical Role of IFN-γ in Experimental Coronavirus RetinopathyInvestigative Ophthalmology & Visual Science, 2003
- Chloroquine: A Multipotent Inhibitor of Human Platelets in VitroThrombosis Research, 2000